Result of AGM

RNS Number : 8820X

Genedrive PLC

29 November 2017

 

For release: 29 November 2017

genedrive plc ("genedrive" or the "Company")

Result of AGM

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held in Manchester today, all resolutions proposed were duly passed.

-  Ends  -

For further details please contact:

genedrive plc	[phone]
David Budd: CEO
Matthew Fowler: CFO
Peel Hunt LLP	[phone]
James Steel
Oliver Jackson
Consilium Strategic Communications	[phone]
Chris Gardner
Matthew Neal
Laura Thornton
[e-mail]

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.

Further details can be found at: www.genedriveplc.com and www.genedrive.com 

 

END

 

 

RAGBSBDBUBDBGRC